Rare Cell Population Analysis in Early-Stage Breast Cancer Patients

Area of Science:

• Oncology
• Cell Biology
• Medical Diagnostics

Background:

• Circulating rare cells are integral to breast cancer progression and offer theranostic potential.
• Current understanding and exploration of cancer-associated rare cells are limited.

Purpose of the Study:

• To investigate and classify circulating rare cell abnormalities in early-stage breast cancer.
• To determine the association of these rare cell markers with tumor presence.

Main Methods:

• Evaluation of a multi-rare-cell detection platform (Rarmax) using fluorescence and cytomorphology.
• Analysis of rare cell populations (including circulating tumor cells) before and after tumor resection in breast cancer patients and controls.

Main Results:

• The Rarmax platform demonstrated linear performance and high recovery rates.
• Specific circulating epithelial and endothelial-like cell subsets were associated with cancer presence, independent of tumor status.
• High sensitivity and specificity were achieved in detecting tumor presence and cancer-associated abnormalities.

Conclusions:

• Cancer-associated rare cell abnormalities can represent both tumor entities and systemic cancer.
• This approach provides a novel method for characterizing the breast cancer system and its systemic spread.